Schizophrenia pharmacoeconomic comparisons

Rascati KL, Johnsrud MT, Crismon ML, et al. Olanzapine versus risperidone in the treatment of schizophrenia A comparison of costs among Texas Medicaid patients. Pharmacoeconomics 2003 21 683—697. 

Almond S, O Donnell O (2000). Cost analysis of the treatment of schizophrenia in the UK a comparison of olanzapine and haloperidol. Pharmacoeconomics 17, 383—9. 

Spannheimer A, Clouth J, Gregor KJ (1999). Pharmacoeconomic evaluation of the rrearmenr of schizophrenia in Germany a comparison of olanzapine, risperidone and haloperidol using a clinical decision model. Poster presented at the ISPOR Second Annual European Meeting, Edinburgh, November 1999. 

---

See also in sourсe #XX -- [ ]

---